FDA Releases Draft Guidance on Public Availability of Advisory Committee Members' Financial Interest Information

Summary

The Food and Drug Administration (FDA) has made available a draft guidance document that outlines procedures for making public certain financial interests and waivers granted to advisory committee members, aiming to increase transparency in the advisory committee process.